Drugging the undruggable: Transcription therapy for cancer

Chunhong Yan, Paul J. Higgins

Research output: Contribution to journalReview article

66 Citations (Scopus)

Abstract

Transcriptional regulation is often the convergence point of oncogenic signaling. It is not surprising, therefore, that aberrant gene expression is a hallmark of cancer. Transformed cells often develop a dependency on such a reprogramming highlighting the therapeutic potential of rectifying cancer-associated transcriptional abnormalities in malignant cells. Although transcription is traditionally considered as undruggable, agents have been developed that target various levels of transcriptional regulation including DNA binding by transcription factors, protein-protein interactions, and epigenetic alterations. Some of these agents have been approved for clinical use or entered clinical trials. While artificial transcription factors have been developed that can theoretically modulate expression of any given gene, the emergence of reliable reporter assays greatly facilitates the search for transcription-targeted agents. This review provides a comprehensive overview of these developments, and discusses various strategies applicable for developing transcription-targeted therapeutic agents.

Original languageEnglish (US)
Pages (from-to)76-85
Number of pages10
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1835
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Transcription Factors
Epigenomics
Neoplasms
Proteins
Clinical Trials
Gene Expression
DNA
Therapeutics
Genes

Keywords

  • Cancer
  • Drug development
  • Targeted therapy
  • Transcription
  • Transcription therapy
  • Transcriptional regulation

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Drugging the undruggable : Transcription therapy for cancer. / Yan, Chunhong; Higgins, Paul J.

In: Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1835, No. 1, 01.01.2013, p. 76-85.

Research output: Contribution to journalReview article

@article{f63ef4ace4e74ce5b35603652d062ff5,
title = "Drugging the undruggable: Transcription therapy for cancer",
abstract = "Transcriptional regulation is often the convergence point of oncogenic signaling. It is not surprising, therefore, that aberrant gene expression is a hallmark of cancer. Transformed cells often develop a dependency on such a reprogramming highlighting the therapeutic potential of rectifying cancer-associated transcriptional abnormalities in malignant cells. Although transcription is traditionally considered as undruggable, agents have been developed that target various levels of transcriptional regulation including DNA binding by transcription factors, protein-protein interactions, and epigenetic alterations. Some of these agents have been approved for clinical use or entered clinical trials. While artificial transcription factors have been developed that can theoretically modulate expression of any given gene, the emergence of reliable reporter assays greatly facilitates the search for transcription-targeted agents. This review provides a comprehensive overview of these developments, and discusses various strategies applicable for developing transcription-targeted therapeutic agents.",
keywords = "Cancer, Drug development, Targeted therapy, Transcription, Transcription therapy, Transcriptional regulation",
author = "Chunhong Yan and Higgins, {Paul J.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.bbcan.2012.11.002",
language = "English (US)",
volume = "1835",
pages = "76--85",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Drugging the undruggable

T2 - Transcription therapy for cancer

AU - Yan, Chunhong

AU - Higgins, Paul J.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Transcriptional regulation is often the convergence point of oncogenic signaling. It is not surprising, therefore, that aberrant gene expression is a hallmark of cancer. Transformed cells often develop a dependency on such a reprogramming highlighting the therapeutic potential of rectifying cancer-associated transcriptional abnormalities in malignant cells. Although transcription is traditionally considered as undruggable, agents have been developed that target various levels of transcriptional regulation including DNA binding by transcription factors, protein-protein interactions, and epigenetic alterations. Some of these agents have been approved for clinical use or entered clinical trials. While artificial transcription factors have been developed that can theoretically modulate expression of any given gene, the emergence of reliable reporter assays greatly facilitates the search for transcription-targeted agents. This review provides a comprehensive overview of these developments, and discusses various strategies applicable for developing transcription-targeted therapeutic agents.

AB - Transcriptional regulation is often the convergence point of oncogenic signaling. It is not surprising, therefore, that aberrant gene expression is a hallmark of cancer. Transformed cells often develop a dependency on such a reprogramming highlighting the therapeutic potential of rectifying cancer-associated transcriptional abnormalities in malignant cells. Although transcription is traditionally considered as undruggable, agents have been developed that target various levels of transcriptional regulation including DNA binding by transcription factors, protein-protein interactions, and epigenetic alterations. Some of these agents have been approved for clinical use or entered clinical trials. While artificial transcription factors have been developed that can theoretically modulate expression of any given gene, the emergence of reliable reporter assays greatly facilitates the search for transcription-targeted agents. This review provides a comprehensive overview of these developments, and discusses various strategies applicable for developing transcription-targeted therapeutic agents.

KW - Cancer

KW - Drug development

KW - Targeted therapy

KW - Transcription

KW - Transcription therapy

KW - Transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=84869861385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869861385&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2012.11.002

DO - 10.1016/j.bbcan.2012.11.002

M3 - Review article

C2 - 23147197

AN - SCOPUS:84869861385

VL - 1835

SP - 76

EP - 85

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

IS - 1

ER -